Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$203.66 USD
+2.83 (1.41%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $203.79 +0.13 (0.06%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | 0.50 |
EPS Last Quarter | 0.03 |
Last EPS Surprise | -85.00% |
ABR | 1.00 |
Earnings ESP
|
34.00% |
---|---|
Current Year | 2.15 |
Next Year | 4.33 |
EPS (TTM) | -1.59 |
P/E (F1) | 94.54 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 59.23M | 62.14M | 249.59M | 371.17M |
# of Estimates | 3 | 2 | 3 | 3 |
High Estimate | 65.34M | 74.40M | 283.07M | 473.81M |
Low Estimate | 47.25M | 49.87M | 195.50M | 251.00M |
Year ago Sales | 0.00M | 8.56M | 50.70M | 249.59M |
Year over Year Growth Est. | NA | 625.88% | 392.30% | 48.71% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.50 | 0.52 | 2.15 | 4.33 |
# of Estimates | 4 | 3 | 7 | 5 |
Most Recent Consensus | 0.67 | 0.47 | 2.57 | 2.96 |
High Estimate | 0.67 | 0.63 | 4.00 | 9.34 |
Low Estimate | 0.37 | 0.31 | 0.89 | 0.34 |
Year ago EPS | -1.25 | -0.67 | -2.76 | 2.15 |
Year over Year Growth Est. | 140.00% | 177.61% | 177.90% | 101.01% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.50 | 0.52 | 2.15 | 4.33 |
7 Days Ago | 0.46 | 0.52 | 2.06 | 4.33 |
30 Days Ago | 0.46 | 0.52 | 2.06 | 4.33 |
60 Days Ago | 0.46 | 0.52 | 2.06 | 4.33 |
90 Days Ago | 0.23 | 0.27 | 1.89 | 3.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.67 | 0.52 | 2.57 | 4.33 |
Zacks Consensus Estimate | 0.50 | 0.52 | 2.15 | 4.33 |
Earnings ESP | 34.00% | 0.00% | 19.30% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.03 | 0.30 | -0.67 | -1.25 | NA |
Estimate | 0.20 | -0.52 | -1.10 | -0.42 | NA |
Difference | -0.17 | 0.82 | 0.43 | -0.83 | 0.06 |
Surprise | -85.00% | 157.69% | 39.09% | -197.62% | -21.46% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more